A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis

NCT03531892 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: AJM300
DRUG: Placebo

Sponsor

EA Pharma Co., Ltd.

Collaborators

[object Object]